Eurobio Scientific SA - Asset Resilience Ratio
Eurobio Scientific SA (ALERS) has an Asset Resilience Ratio of 10.52% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ALERS total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2007–2024)
This chart shows how Eurobio Scientific SA's Asset Resilience Ratio has changed over time. See ALERS book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Eurobio Scientific SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ALERS stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €26.86 Million | 10.37% |
| Short-term Investments | €393.00K | 0.15% |
| Total Liquid Assets | €27.25 Million | 10.52% |
Asset Resilience Insights
- Moderate Liquidity: Eurobio Scientific SA has 10.52% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Eurobio Scientific SA Industry Peers by Asset Resilience Ratio
Compare Eurobio Scientific SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Inspiration Healthcare Group PLC
LSE:IHC |
Medical Devices | 0.15% |
|
Clearpoint Neuro Inc
NASDAQ:CLPT |
Medical Devices | 0.00% |
|
Arcoma AB
ST:ARCOMA |
Medical Devices | 18.92% |
|
Guangdong Biolight Meditech Co Ltd
SHE:300246 |
Medical Devices | 0.73% |
|
Semler Scientific Inc
NASDAQ:SMLR |
Medical Devices | 0.00% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Xylo Technologies Ltd.
NASDAQ:XYLO |
Medical Devices | 15.76% |
|
Cardiex Ltd
AU:CDX |
Medical Devices | 0.16% |
Annual Asset Resilience Ratio for Eurobio Scientific SA (2007–2024)
The table below shows the annual Asset Resilience Ratio data for Eurobio Scientific SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 9.47% | €24.36 Million ≈ $28.47 Million |
€257.17 Million ≈ $300.66 Million |
-31.23pp |
| 2023-12-31 | 40.70% | €128.76 Million ≈ $150.53 Million |
€316.33 Million ≈ $369.82 Million |
+3.06pp |
| 2022-12-31 | 37.64% | €124.38 Million ≈ $145.41 Million |
€330.42 Million ≈ $386.29 Million |
-15.82pp |
| 2021-12-31 | 53.46% | €111.85 Million ≈ $130.77 Million |
€209.22 Million ≈ $244.61 Million |
+15.15pp |
| 2020-12-31 | 38.31% | €66.01 Million ≈ $77.18 Million |
€172.30 Million ≈ $201.43 Million |
+28.16pp |
| 2019-12-31 | 10.15% | €8.22 Million ≈ $9.61 Million |
€81.01 Million ≈ $94.70 Million |
-7.19pp |
| 2018-12-31 | 17.34% | €12.12 Million ≈ $14.17 Million |
€69.90 Million ≈ $81.72 Million |
-1.02pp |
| 2017-12-31 | 18.36% | €13.14 Million ≈ $15.36 Million |
€71.57 Million ≈ $83.68 Million |
-8.91pp |
| 2016-12-31 | 27.27% | €8.70 Million ≈ $10.17 Million |
€31.89 Million ≈ $37.28 Million |
+7.39pp |
| 2015-12-31 | 19.88% | €7.10 Million ≈ $8.30 Million |
€35.71 Million ≈ $41.75 Million |
-7.64pp |
| 2014-12-31 | 27.52% | €11.14 Million ≈ $13.03 Million |
€40.50 Million ≈ $47.35 Million |
+19.90pp |
| 2013-12-31 | 7.62% | €2.55 Million ≈ $2.98 Million |
€33.41 Million ≈ $39.06 Million |
-0.55pp |
| 2012-12-31 | 8.16% | €3.14 Million ≈ $3.67 Million |
€38.49 Million ≈ $45.00 Million |
-22.12pp |
| 2011-12-31 | 30.28% | €5.33 Million ≈ $6.23 Million |
€17.60 Million ≈ $20.58 Million |
-35.12pp |
| 2010-12-31 | 65.40% | €20.45 Million ≈ $23.90 Million |
€31.26 Million ≈ $36.55 Million |
-11.60pp |
| 2009-12-31 | 77.00% | €28.14 Million ≈ $32.90 Million |
€36.55 Million ≈ $42.73 Million |
+25.39pp |
| 2008-12-31 | 51.61% | €15.40 Million ≈ $18.01 Million |
€29.85 Million ≈ $34.89 Million |
-14.74pp |
| 2007-12-31 | 66.34% | €24.94 Million ≈ $29.16 Million |
€37.59 Million ≈ $43.95 Million |
-- |
About Eurobio Scientific SA
Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monito… Read more